Parametric Portfolio Associates LLC grew its stake in Vitamin Shoppe, Inc (NYSE:VSI) by 71.2% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 128,156 shares of the specialty retailer’s stock after purchasing an additional 53,279 shares during the quarter. Parametric Portfolio Associates LLC owned about 0.55% of Vitamin Shoppe worth $1,493,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the company. California Public Employees Retirement System lifted its stake in shares of Vitamin Shoppe by 37.3% in the 2nd quarter. California Public Employees Retirement System now owns 82,100 shares of the specialty retailer’s stock valued at $956,000 after purchasing an additional 22,300 shares during the period. FMR LLC lifted its stake in shares of Vitamin Shoppe by 32.4% in the 2nd quarter. FMR LLC now owns 1,254,690 shares of the specialty retailer’s stock valued at $14,617,000 after purchasing an additional 307,050 shares during the period. Pinebridge Investments L.P. lifted its stake in shares of Vitamin Shoppe by 37.5% in the 2nd quarter. Pinebridge Investments L.P. now owns 49,682 shares of the specialty retailer’s stock valued at $579,000 after purchasing an additional 13,548 shares during the period. UBS Asset Management Americas Inc. lifted its stake in shares of Vitamin Shoppe by 17,041.4% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 11,999 shares of the specialty retailer’s stock valued at $140,000 after purchasing an additional 11,929 shares during the period. Finally, Quantitative Investment Management LLC lifted its stake in shares of Vitamin Shoppe by 69.0% in the 2nd quarter. Quantitative Investment Management LLC now owns 67,600 shares of the specialty retailer’s stock valued at $787,000 after purchasing an additional 27,600 shares during the period. 98.39% of the stock is currently owned by institutional investors.

Shares of Vitamin Shoppe, Inc (VSI) opened at $3.80 on Tuesday. The company has a market cap of $83.92, a price-to-earnings ratio of 3.76 and a beta of 0.74. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.07 and a quick ratio of 0.32. Vitamin Shoppe, Inc has a 1 year low of $2.95 and a 1 year high of $26.60.

Vitamin Shoppe (NYSE:VSI) last released its earnings results on Wednesday, November 8th. The specialty retailer reported ($0.03) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.17 by ($0.20). The firm had revenue of $288.20 million for the quarter, compared to the consensus estimate of $297.61 million. Vitamin Shoppe had a positive return on equity of 6.17% and a negative net margin of 20.27%. Vitamin Shoppe’s revenue for the quarter was down 8.5% on a year-over-year basis. During the same quarter last year, the company posted $0.50 EPS. research analysts expect that Vitamin Shoppe, Inc will post 0.53 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Parametric Portfolio Associates LLC Has $1.49 Million Stake in Vitamin Shoppe, Inc (VSI)” was posted by Daily Political and is the property of of Daily Political. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be read at https://www.dailypolitical.com/2017/11/14/parametric-portfolio-associates-llc-has-1-49-million-stake-in-vitamin-shoppe-inc-vsi.html.

In other news, Director John D. Bowlin bought 40,000 shares of the stock in a transaction on Friday, August 25th. The stock was purchased at an average price of $5.50 per share, for a total transaction of $220,000.00. Following the acquisition, the director now owns 56,028 shares in the company, valued at $308,154. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 1.07% of the stock is currently owned by corporate insiders.

A number of analysts recently commented on VSI shares. Morgan Stanley set a $8.00 price objective on shares of Vitamin Shoppe and gave the company a “hold” rating in a research report on Thursday, August 10th. Barclays PLC lowered their price objective on shares of Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating for the company in a research report on Thursday, November 9th. Goldman Sachs Group, Inc. (The) restated a “sell” rating and issued a $6.00 price objective (down previously from $13.00) on shares of Vitamin Shoppe in a research report on Thursday, August 10th. TheStreet cut shares of Vitamin Shoppe from a “c-” rating to a “d” rating in a research report on Wednesday, August 9th. Finally, BidaskClub cut shares of Vitamin Shoppe from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. Four investment analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $5.00.

Vitamin Shoppe Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Institutional Ownership by Quarter for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.